Affiliation:
1. Shanghai University of Engineering Science
2. Shanghai Jiao Tong University School of Medicine
3. University of the Punjab Quaid-i-Azam Campus: University of the Punjab
4. Donghua University
5. University of Sargodha
Abstract
Abstract
Objective:
Vascular catheter-related infections and thrombosis are common and may lead to serious complications after catheterization. Reducing the incidence of such infections has become a significant challenge. This study aims to develop a super hydrophobic nanocomposite drug-loaded vascular catheter that can effectively resist bacterial infections and blood coagulation.
Methods:
In this study, a SiO2 nanocoated PTFE (Polytetrafluoroethylene) catheter (PTFE-SiO2) was prepared and further optimized to prepare a SiO2 nanocoated PTFE catheter loaded with imipenem/cilastatin sodium (PTFE-IC@dMSNs). The catheters were characterized for performance, cell compatibility, anticoagulant performance, in vitro and in vivo antibacterial effect and biological safety.
Result:
PTFE-IC@dMSNs catheter has efficient drug loading performance and drug release rate and has good cell compatibility and anticoagulant effect in vitro. Compared with the PTFE-SiO2 catheter, the inhibition ring of the PTFE-IC@dMSNs catheter against Escherichia coli increased from 3.985 mm2 to 4.561 mm2, and the antibacterial rate increased from about 50.8% to 56.9%, with significant difference (p<0.05). The antibacterial zone against Staphylococcus aureus increased from 8.633 mm2 to 11.735 mm2, and the antibacterial rate increased from approximately 83.5% to 89.3%, showing a significant difference (p<0.05). PTFE-IC@dMSNs catheter also has good biocompatibility in vivo.
Conclusion:
Compared with PTFE, PTFE-SiO2 and PTFE-IC@dMSNs catheters have good characterization performance, cell compatibility, and anticoagulant properties. PTFE SiO2 and PTFE-IC@dMSNs catheters have good antibacterial performance and tissue safety against E. coli and S. aureus. Relatively, PTFE-SiO2 and PTFE-IC@dMSNs catheter has better antibacterial properties and histocompatibility and has potential application prospects in anti-bacterial catheter development and anticoagulation.
Publisher
Research Square Platform LLC
Reference59 articles.
1. Urtecho M, Torres Roldan VD, Nayfeh T, Espinoza Suarez NR, Ranganath N, Sampathkumar P, et al. editors. Comparing complication rates of midline catheter vs. peripherally inserted central catheter (PICC). A systematic review and meta-analysis. Open Forum Infectious Diseases; 2023.
2. Catheter-Related Bloodstream Infection With Femoral Central Access Versus Internal Jugular Access in Patients Admitting to Medical Intensive Care Unit;Hafeez SB;Cureus,2022
3. Bedside ultrasound as a screening test for the diagnosis of catheter-related bloodstream infection (CRBI);Sio C;J Ultrasound,2021
4. The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis;Bosch C;J Hosp Infect,2022
5. Comparison of 2 midline catheter devices with differing antithrombogenic mechanisms for catheter-related thrombosis: a randomized clinical trial;Bahl A;JAMA Netw Open,2021